FDA Inspection 1004204 — Puma Biotechnology, Inc.
The FDA completed an inspection of Puma Biotechnology, Inc. on March 17, 2017 in Los Angeles, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 17, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Los Angeles, CA (United States)
Additional Details
Sponsor, Contract Research Organization